The Office of Research and International Relations officially changed its name to the Office of Research and Innovation (R&I), as of June 1, 2016. 

Published on: 13 Jun 2016

Montreal - The Board of Governors of McGill University is pleased to announce that Dr. Suzanne Fortier has been selected as the University’s 17th Principal and Vice-Chancellor. Her five-year term will begin in early September 2013.

Category:
Published on: 5 Mar 2013

McGill University and Intellectual Ventures have announced a partnership that provides an additional avenue for McGill faculty to commercialize their inventions and discoveries.

Published on: 7 Aug 2012

We’ve known for a while that the vestibular system in the inner ear is responsible for helping us keep our balance. And while researchers have already developed a basic understanding of how the brain constructs our perceptions of ourselves in motion, until now no one has understood the crucial step by which the neurons in the brain select the information needed to do so.

Published on: 24 Jul 2012

Following media reports on its spending on security during student unrest earlier this year, McGill University reiterates that this spending was both responsible and effective, said Olivier Marcil, Vice-Principal (Communications and External Relations).

Published on: 9 Jul 2012

Fourteen of the 156 new 2012 Vanier Scholars will be attending McGill University, coming from countries as diverse as Australia, Belgium, Peru and the United States, as well as from Canada.

Published on: 3 Jul 2012

Two projects led by McGill professors are among the 17 that will receive a total of $28 million over six years to help science and engineering graduates add job skills to their academic achievements, thanks to the.Natural Sciences and Engineering Research Council of Canada’s (NSERC) CREATE program. The two projects are the CREATE program in green chemistry led by Prof. Chao-Jun Li, and the CREATE

Published on: 26 Jun 2012

A new study published in the journal Arthritis Care & Research, led by Dr. Mary-Ann Fitzcharles, a rheumatologist at the McGill University Health Centre, reveals that 13 per cent of FM patients use cannabinoids for relief from symptoms such as widespread pain, fatigue, and insomnia.

Published on: 22 Jun 2012

Pages

Back to top